abstract |
The present invention relates to a composition comprising an inhibitor of human histone methyltransferase EZH2 and one or more other therapeutic agents, in particular an anticancer agent, such as prednisone, and methods of combination therapy for administration to a subject in need thereof for the treatment of cancer. . |